In summary, our research delivered evidence at multiple levels for the crucial role of RAI2 in GC growth and invasion and its capacity as a predictor in immunotherapy for GC through reducing PD-L1 expression in conjunction with being relevant to TILs (Figure 8). Here, CD274 is linked to gastric cancer.